• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.69% Nasdaq Down 1.07%

    Epizyme, Inc. (EPZM)

    -NasdaqGS
    20.00 Down 0.10(0.50%) 4:00PM EDT
    |After Hours : 20.00 Down 0.00 (0.02%) 4:41PM EDT
    Add to Portfolio
    Prev Close:20.10
    Open:19.86
    Bid:19.00 x 200
    Ask:20.50 x 200
    1y Target Est:32.50
    Beta:0.680665
    Earnings Date:Nov 4 - Nov 9 (Est.)
    Day's Range:19.08 - 21.28
    52wk Range:13.67 - 34.52
    Volume:620,488
    Avg Vol (3m):514,852
    Market Cap:826.59M
    P/E (ttm):N/A
    EPS (ttm):-3.39
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    EPZMDown 0.50%826.59M
    GSKDown 0.78%98.93B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):41.18
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-3.77
    Quarterly EPS Est (Sep-15) :-0.61
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies for cancer patients. Its proprietary product platform creates small molecule inhibitors of a 96-member class of enzymes known as histone methylt... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback